DAWN vs GILD: Which Stock is Better?
Side-by-side comparison of Day One Biopharmaceuticals Inc and Gilead Sciences Inc in 2026
DAWN
Day One Biopharmaceuticals Inc
—
GILD
Gilead Sciences Inc
$129.16
Key Metrics Comparison
| Metric | DAWN | GILD | Winner |
|---|---|---|---|
| Market Cap | $656.83M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze DAWN
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is DAWN or GILD a better investment?
Comparing DAWN and GILD: Day One Biopharmaceuticals Inc has a market cap of $656.83M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between DAWN and GILD?
DAWN (Day One Biopharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: DAWN or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: DAWN or GILD?
Both DAWN and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: DAWN or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: DAWN or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $656.83M for DAWN.
Should I buy DAWN or GILD in 2026?
Both DAWN and GILD have investment merit. DAWN trades at $N/A while GILD trades at $129.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between DAWN and GILD stock?
Key differences: Market Cap ($656.83M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy DAWN or GILD in 2026?
The choice between DAWN and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between DAWN and GILD?
DAWN (Day One Biopharmaceuticals Inc) has a market cap of $656.83M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.